SIRT6 knockdown in NASH mouse models led to increased transcription and expression of NF-κB target genes as well as higher levels of inflammatory factors such as TNF-α and IL-1β in the liver. The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatohepatitis.